ReviewNutrients2026
Coffee and Caffeine in Depression: Symptom-Level Modulation and Challenges in Nutripsychiatric Interpretation.
Review in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEvidence on the relationship between coffee, caffeine and depression remains inconsistent. Observational studies often report inverse associations, whereas experimental findings indicate potential adverse effects on anxiety and sleep. As a psychostimulant, caffeine increases alertness and perceived energy and may transiently improve mood and task engagement.
objectiveThis narrative review aims to reinterpret existing evidence on coffee and caffeine in depression from a symptom-level perspective, with emphasis on sleep-wake regulation, anxiety sensitivity, habitual use and withdrawal-related phenomena.
methodsHuman studies published between 2000 and 2025 were synthesised narratively based on their relevance to depressive symptoms, arousal regulation, sleep and behavioural patterns of caffeine use, rather than for pooled effect estimation.
resultsCaffeine may transiently alleviate fatigue and psychomotor slowing, but these effects are context-dependent and frequently counterbalanced by sleep disruption, anxiety and withdrawal-related fluctuations. Inverse associations observed in cohort studies may partly reflect reverse causality, residual confounding and relief of withdrawal symptoms rather than true antidepressant effects.
conclusionsCoffee and caffeine should not be conceptualised as antidepressant interventions. Instead, they appear to act as context-dependent modulators of symptom expression in depression, particularly affecting fatigue, alertness and sleep-wake stability. Failure to account for dose, habitual use, withdrawal and individual vulnerability may lead to overinterpretation of epidemiological findings in nutripsychiatric research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.